Skip to content
跳至主要內容
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
Stock detail
Loading institutional stock data...
← BACK TO COCKPIT
ALL TICKERS →
OPTIONS CHAIN →
PACB
Pacific Biosciences of California, Inc.
NASDAQGS
Medical Devices
United States
$1.35
▲
+0.05 (+3.85%)
CLOSED
—
OPEN
$1.30
HIGH
$1.35
AT HIGH
LOW
$1.29
PREV CLOSE
$1.30
VOLUME
2.76M
0.42x avg
BID / ASK
0.95 / 1.66
spr 0.710
MARKET CAP
$419.6M
DAY RANGE
$1.29
$1.35
P/E (TTM)
—
Fwd -3.3
EPS (TTM)
-0.44
DIV YIELD
—
52W HIGH
$2.73
-50.5%
52W LOW
$1.07
+26.2%
BETA
2.31
vs S&P 500
DES
FA
GP
OPT
HLDR
EARN
CMP
COMPARE
ASK DESK
AFTER-HOURS
$1.35
-0.00
(-0.21%)
LAST SURPRISE
—
—
NEXT EARNINGS
—
—
CATALYST
No fresh catalyst
—
ANALYST
—
—
SHORT INT
—
—
OPTIONS IV
—
—
PACB
$1.35
▲
+3.85%
Chart
Valuation
Financials
Peers
News
PACB · K 線技術分析（即時、可互動）
basic
pro
快速分析（約 90–120 秒）
K 線圖載入中…
按上方「快速分析」，研究台會以這張 K 線為起點跑一輪快速回答：三個分析師視角（總經、基本面、技術面）加交易計畫與風險統計，約 90–120 秒。想要五隊深度研究與機構級報告，請在研究台把模式切到「深度」。
1-YEAR PRICE
One-Year Trajectory
MIXED
252 BARS · +6.3% YOY
1-year price chart. Started at 1.27, currently 1.35, up 6.3 percent. Range 1.11 to 2.67 over 252 data points.
2025-09-05
$1.27 → $1.35 (+6.3%)
2026-09-04
§ Valuation
Loading § Valuation
§ Multi-Year Financials
Loading § Multi-Year Financials
§ Peers
Loading § Peers
§ Recent News
Loading § Recent News
EDITORIAL · NOT INVESTMENT ADVICE.
Data sources: Finnhub (quote / profile / news / peers) + Yahoo (stats) + SEC EDGAR XBRL (financials + DCF). All values cached for 5 minutes via ISR.
VALUATION
Deterministic Valuation (SEC EDGAR + Finnhub)
—
NO DCF
DCF Fair Value
—
DCF vs Spot
—
Comps Fair Value
—
WACC Used
+7.5%
Terminal g
+3.0%
Peers:
CYRX
MLAB PE150
OABI
CTKB
DNA
TKNO
LAB
QSI
⚠ DCF skipped: missing FCF or shares data from SEC EDGAR. Often the case for non-US issuers.
FINANCIALS
Multi-Year Financials (SEC XBRL)
—
4 FY · NO YOY
FY
Revenue
Net Income
OCF
FCF
Assets
2025-12
—
-$546.4M
-$111.2M
-$113.9M
$784.1M
2024-12
—
-$309.9M
-$206.1M
-$212.2M
$1.26B
2023-12
—
-$306.7M
-$259.2M
-$268.0M
$1.75B
2018-12
$78.6M
—
—
—
—
PEERS
Sector & Industry Peers
CALM
10 PEERS · FINNHUB
CYRX
MLAB
OABI
CTKB
DNA
TKNO
LAB
QSI
LFCR
CDXS
NEWS
Recent News (past 14 days)
CALM
10 HEADLINES · LAST 14 DAYS
Pacific Biosciences (PACB) Up 11.6% Since Last Earnings Report: Can It Continue?
Zacks · 2026-09-04
PacBio to Participate in the Morgan Stanley 24ᵗʰ Annual Global Healthcare Conference
GlobeNewswire · 2026-09-03
10x Genomics Rallies 84% in 3 Months: Is There More Upside Ahead?
Zacks · 2026-09-03
PACB Cuts 2026 Outlook as Clinical Adoption Faces Its Crucial Test
Zacks · 2026-09-02
3 Reasons to Sell PACB and 1 Stock to Buy Instead
StockStory · 2026-09-02
1 of Wall Street’s Favorite Stocks to Own for Decades and 2 We Brush Off
StockStory · 2026-08-26
Cancer Vaccine Breakthrough Lifts 5 Biotech Names. Here’s Who’s Best Positioned.
24/7 Wall St. · 2026-08-25
1 Healthcare Stock to Target This Week and 2 Facing Headwinds
StockStory · 2026-08-24